Renos Savva

PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom.

BioMoti Ltd. provides cancer treatment and health care services. It offers a new class of immunotherapeutic drug-loaded particles that target and gain entry to the tumor vasculature and cancer cells. The company was founded by Joanne Martin and Davidson Ateh on June 6, 2009 and is headquartered in London, the United Kingdom.

The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom.

Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom.

UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom.

Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom.

Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom.

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom.